Alberta Investment Management Corp Boosts Holdings in Kenvue Inc. $KVUE

Alberta Investment Management Corp grew its stake in shares of Kenvue Inc. (NYSE:KVUE) by 50.1% in the fourth quarter, HoldingsChannel reports. The fund owned 1,661,616 shares of the company’s stock after buying an additional 554,900 shares during the quarter. Alberta Investment Management Corp’s holdings in Kenvue were worth $28,663,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of KVUE. Physician Wealth Advisors Inc. lifted its position in Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after buying an additional 618 shares in the last quarter. Elyxium Wealth LLC acquired a new stake in shares of Kenvue in the fourth quarter worth $26,000. SBI Securities Co. Ltd. raised its stake in shares of Kenvue by 82.4% in the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after acquiring an additional 1,027 shares during the period. Leonteq Securities AG purchased a new position in shares of Kenvue in the 4th quarter valued at $45,000. Finally, DV Equities LLC acquired a new position in shares of Kenvue during the 4th quarter valued at $46,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.59% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages recently weighed in on KVUE. Barclays decreased their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday. UBS Group decreased their target price on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, April 7th. Argus raised Kenvue to a “hold” rating in a research report on Friday, March 6th. Finally, Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat.com, Kenvue currently has a consensus rating of “Hold” and a consensus price target of $19.33.

Kenvue Stock Up 0.9%

Shares of NYSE KVUE opened at $18.17 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The stock’s 50-day simple moving average is $17.52 and its 200-day simple moving average is $17.57. The firm has a market cap of $34.88 billion, a price-to-earnings ratio of 21.37, a PEG ratio of 1.37 and a beta of 0.54.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm’s revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.24 EPS. As a group, equities analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.